(Q43788592)

English

Clinical significance of antibody against oxidized low density lipoprotein in patients with atherosclerotic coronary artery disease

scientific article published in March 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

26 November 2017

Clinical significance of antibody against oxidized low density lipoprotein in patients with atherosclerotic coronary artery disease (English)

1 reference

Europe PubMed Central

26 November 2017

atherosclerosis

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Inoue T

1

1 reference

Europe PubMed Central

26 November 2017

Uchida T

2

1 reference

Europe PubMed Central

26 November 2017

Kamishirado H

3

1 reference

Europe PubMed Central

26 November 2017

Takayanagi K

4

1 reference

Europe PubMed Central

26 November 2017

Hayashi T

5

1 reference

Europe PubMed Central

26 November 2017

Morooka S

6

1 reference

Europe PubMed Central

26 November 2017

language of work or name

0 references

publication date

1 March 2001

1 reference

Europe PubMed Central

26 November 2017

Journal of the American College of Cardiology

1 reference

Europe PubMed Central

26 November 2017

37

1 reference

Europe PubMed Central

26 November 2017

3

1 reference

Europe PubMed Central

26 November 2017

775-779

1 reference

Europe PubMed Central

26 November 2017

Role of oxidized low density lipoprotein in atherogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901199-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901199-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901199-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Elevated serum neopterin levels in atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901199-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Antibody against oxidized low-density lipoprotein predicting myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901199-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Specificity of autoantibodies against oxidized LDL as an additional marker for atherosclerotic risk

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901199-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Autoantibodies against oxidized low density lipoprotein in patients with angiographically verified coronary artery disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901199-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Autoantibody against oxidised LDL and progression of carotid atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901199-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Patients with early-onset peripheral vascular disease have increased levels of autoantibodies against oxidized LDL

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901199-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Autoantibodies against oxidized LDL do not predict atherosclerotic vascular disease in non-insulin-dependent diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901199-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Transient reduction of autoantibodies against oxidized LDL in patients with acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901199-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Malondialdehyde alteration of low density lipoproteins leads to cholesteryl ester accumulation in human monocyte-macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901199-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Endothelial and smooth muscle cells alter low density lipoprotein in vitro by free radical oxidation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901199-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901199-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Endothelial cell-derived chemotactic activity for mouse peritoneal macrophages and the effects of modified forms of low density lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901199-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Lipid peroxides and atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901199-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Predisposition to LDL oxidation in patients with and without angiographically established coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901199-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Vitamin E consumption and the risk of coronary heart disease in men.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901199-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Vitamin E consumption and the risk of coronary disease in women.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901199-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Oxidatively modified LDL contains phospholipids with platelet-activating factor-like activity and stimulates the growth of smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901199-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Lewis A. Conner Memorial Lecture. Oxidative modification of LDL and atherogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901199-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901199-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Antibodies to oxidized lipoproteins and their relationship to myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901199-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Antibodies against cardiolipin and oxidatively modified LDL in 50-year-old men predict myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901199-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0735-1097(00)01199-2

1 reference

Europe PubMed Central

26 November 2017

1 reference

Europe PubMed Central

26 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43788592&oldid=2103342856"